Cullen/Frost Bankers’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.96M Buy
12,439
+231
+2% +$48K 0.03% 256
2026
Q1
$2.58M Buy
12,208
+89
+0.7% +$19.2K 0.03% 258
2025
Q4
$2.49M Buy
12,119
+304
+3% +$57.2K 0.03% 263
2025
Q3
$1.85M Buy
11,815
+215
+2% +$33.2K 0.02% 272
2025
Q2
$1.95M Buy
11,600
+573
+5% +$85K 0.02% 261
2025
Q1
$1.52M Sell
11,027
-557
-5% -$71K 0.02% 267
2024
Q4
$1.37M Sell
11,584
-1,357
-10% -$158K 0.02% 274
2024
Q3
$1.43M Sell
12,941
-2,641
-17% -$276K 0.02% 267
2024
Q2
$1.53M Sell
15,582
-1,811
-10% -$185K 0.02% 258
2024
Q1
$1.95M Sell
17,393
-667
-4% -$72K 0.03% 248
2023
Q4
$1.82M Sell
18,060
-1,772
-9% -$176K 0.03% 255
2023
Q3
$1.72M Sell
19,832
-1,198
-6% -$108K 0.03% 253
2023
Q2
$1.99M Sell
21,030
-4,736
-18% -$400K 0.03% 247
2023
Q1
$1.95M Sell
25,766
-4,876
-16% -$368K 0.04% 246
2022
Q4
$2.36M Sell
30,642
-4,589
-13% -$349K 0.04% 230
2022
Q3
$2.35M Sell
35,231
-11,913
-25% -$755K 0.05% 217
2022
Q2
$2.47M Sell
47,144
-77,467
-62% -$4.4M 0.06% 218
2022
Q1
$7.07M Buy
124,611
+11,944
+11% +$640K 0.14% 155
2021
Q4
$5.81M Buy
112,667
+373
+0.3% +$18.3K 0.11% 172
2021
Q3
$5.56M Buy
112,294
+12,482
+13% +$677K 0.11% 176
2021
Q2
$5.7M Buy
99,812
+8,811
+10% +$515K 0.11% 174
2021
Q1
$5.53M Buy
91,001
+3,389
+4% +$187K 0.12% 169
2020
Q4
$4.7M Buy
87,612
+2,011
+2% +$104K 0.11% 172
2020
Q3
$4.02M Buy
85,601
+5,439
+7% +$279K 0.1% 173
2020
Q2
$4.19M Buy
80,162
+24,632
+44% +$1.27M 0.11% 174
2020
Q1
$2.67M Buy
55,530
+29,110
+110% +$1.51M 0.09% 185
2019
Q4
$1.34M Buy
26,420
+7,519
+40% +$388K 0.04% 251
2019
Q3
$892K Buy
18,901
+5,029
+36% +$230K 0.03% 272
2019
Q2
$655K Buy
13,872
+2,184
+19% +$101K 0.02% 280
2019
Q1
$563K Buy
11,688
+1,241
+12% +$62.2K 0.02% 284
2018
Q4
$466K Sell
10,447
-2,340
-18% -$122K 0.02% 290
2018
Q3
$690K Sell
12,787
-803
-6% -$41.1K 0.02% 269
2018
Q2
$663K Sell
13,590
-2,476
-15% -$140K 0.02% 270
2018
Q1
$1.01M Buy
16,066
+92
+0.6% +$6.31K 0.03% 247
2017
Q4
$978K Sell
15,974
-71,498
-82% -$4.42M 0.03% 241
2017
Q3
$5.85M Buy
87,472
+32,387
+59% +$2.29M 0.19% 139
2017
Q2
$4.29M Buy
55,085
+40,667
+282% +$3.07M 0.14% 158
2017
Q1
$1.18M Sell
14,418
-833
-5% -$65.6K 0.04% 230
2016
Q4
$1.1M Buy
15,251
+1,654
+12% +$120K 0.04% 237
2016
Q3
$1.06M Sell
13,597
-507
-4% -$41K 0.04% 237
2016
Q2
$1.1M Sell
14,104
-8,035
-36% -$641K 0.04% 235
2016
Q1
$1.81M Buy
22,139
+7,253
+49% +$590K 0.07% 195
2015
Q4
$1.33M Buy
14,886
+134
+0.9% +$11.4K 0.05% 221
2015
Q3
$1.13M Buy
14,752
+140
+1% +$11.7K 0.05% 223
2015
Q2
$1.22M Sell
14,612
-439
-3% -$38.8K 0.05% 229
2015
Q1
$1.36M Sell
15,051
-12,423
-45% -$1.07M 0.05% 224
2014
Q4
$2.22M Sell
27,474
-2,089
-7% -$165K 0.09% 189
2014
Q3
$2.21M Sell
29,563
-136
-0.5% -$9.9K 0.09% 183
2014
Q2
$2.04M Sell
29,699
-2,040
-6% -$139K 0.08% 195
2014
Q1
$2.22M Buy
31,739
+13,144
+71% +$914K 0.1% 184
2013
Q4
$1.24M Sell
18,595
-709
-4% -$43.3K 0.06% 222
2013
Q3
$1.01M Sell
19,304
-11,813
-38% -$600K 0.05% 233
2013
Q2
$1.47M Buy
+31,117
New +$1.42M 0.08% 200

Other funds holding CAH

Cullen/Frost Bankers's CAH Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Cardinal Health (CAH) stake by 1.9% in Q2 2026, buying an estimated $48K and bringing the position to 12,439 shares worth $2.96M. The position accounts for 0.03% of the portfolio, ranked #256.

Cullen/Frost Bankers first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.07M in Q1 2022. 857 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Cullen/Frost Bankers held 12,439 shares of Cardinal Health worth $2.96M as of Q2 2026.
  • Cullen/Frost Bankers bought 231 Cardinal Health shares in Q2 2026, an estimated $48K.
  • Cardinal Health made up 0.03% of Cullen/Frost Bankers's portfolio in Q2 2026, its #256 holding.
  • Cullen/Frost Bankers first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
  • Cullen/Frost Bankers's Cardinal Health position peaked at $7.07M in Q1 2022.
  • 857 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.